Hospital Mater Dei S.A.

BOVESPA:MATD3 Stock Report

Market Cap: R$1.6b

Hospital Mater Dei Future Growth

Future criteria checks 3/6

Hospital Mater Dei is forecast to grow earnings and revenue by 70.2% and 6.7% per annum respectively. EPS is expected to grow by 67.1% per annum. Return on equity is forecast to be 11.4% in 3 years.

Key information

70.2%

Earnings growth rate

67.1%

EPS growth rate

Healthcare earnings growth29.3%
Revenue growth rate6.7%
Future return on equity11.4%
Analyst coverage

Good

Last updated01 May 2025

Recent future growth updates

Hospital Mater Dei S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 10
Hospital Mater Dei S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

Hospital Mater Dei S.A.'s (BVMF:MATD3) 26% Share Price Surge Not Quite Adding Up

May 01
Hospital Mater Dei S.A.'s (BVMF:MATD3) 26% Share Price Surge Not Quite Adding Up

Hospital Mater Dei S.A.'s (BVMF:MATD3) Share Price Could Signal Some Risk

Jan 31
Hospital Mater Dei S.A.'s (BVMF:MATD3) Share Price Could Signal Some Risk

Hospital Mater Dei S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 10
Hospital Mater Dei S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

What You Can Learn From Hospital Mater Dei S.A.'s (BVMF:MATD3) P/E After Its 26% Share Price Crash

Apr 27
What You Can Learn From Hospital Mater Dei S.A.'s (BVMF:MATD3) P/E After Its 26% Share Price Crash

Robust Earnings May Not Tell The Whole Story For Hospital Mater Dei (BVMF:MATD3)

Aug 19
Robust Earnings May Not Tell The Whole Story For Hospital Mater Dei (BVMF:MATD3)

Earnings and Revenue Growth Forecasts

BOVESPA:MATD3 - Analysts future estimates and past financials data (BRL Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20272,7092443543794
12/31/20262,4892082403576
12/31/20252,2631444943607
12/31/20242,226-338-81132N/A
9/30/20242,280-321-71176N/A
6/30/20242,278-368-70160N/A
3/31/20242,246135-61157N/A
12/31/20232,188120-39157N/A
9/30/20232,159108-101118N/A
6/30/20232,064113-16577N/A
3/31/20231,944104-145110N/A
12/31/20221,763104-24898N/A
9/30/20221,539111-272137N/A
6/30/20221,306121-284172N/A
3/31/20221,140145-282175N/A
12/31/20211,024145-193153N/A
6/30/2021899130-10446N/A
3/31/202177484-6238N/A
12/31/202071873480N/A
12/31/20197331383101N/A
12/31/201862712417169N/A
12/31/2017600108N/A179N/A
12/31/201652586N/A126N/A
12/31/201543053N/A55N/A
12/31/201431951N/A104N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MATD3 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (10.8%).

Earnings vs Market: MATD3 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MATD3 is expected to become profitable in the next 3 years.

Revenue vs Market: MATD3's revenue (6.7% per year) is forecast to grow slower than the BR market (7% per year).

High Growth Revenue: MATD3's revenue (6.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MATD3's Return on Equity is forecast to be low in 3 years time (11.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 04:36
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hospital Mater Dei S.A. is covered by 10 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Flavio YoshidaBofA Global Research
Marcio OsakoBradesco S.A. Corretora de Títulos e Valores Mobiliários
Frederico MendesBradesco S.A. Corretora de Títulos e Valores Mobiliários